Sensei Biotherapeutics, Inc.
SNSE
$0.3857
-$0.0192-4.74%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -7.77M | -7.25M | -7.14M | -7.99M | -7.41M |
| Total Depreciation and Amortization | 331.00K | 332.00K | 328.00K | 331.00K | 329.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.40M | 848.00K | 937.00K | 1.47M | 1.32M |
| Change in Net Operating Assets | 250.00K | 603.00K | 85.00K | -1.43M | -400.00K |
| Cash from Operations | -5.79M | -5.47M | -5.79M | -7.62M | -6.16M |
| Capital Expenditure | 0.00 | 0.00 | -109.00K | -37.00K | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.15M | 12.91M | 7.02M | 5.81M | 8.26M |
| Cash from Investing | -3.15M | 12.91M | 6.91M | 5.77M | 8.26M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -207.00K | -204.00K | -201.00K | -199.00K | -196.00K |
| Issuance of Common Stock | 13.00K | 0.00 | 21.00K | -- | 17.00K |
| Repurchase of Common Stock | 0.00 | 0.00 | 0.00 | -10.00K | -252.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -194.00K | -204.00K | -180.00K | -209.00K | -431.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.14M | 7.24M | 935.00K | -2.06M | 1.67M |